| Company Name: | UnitedHealth Group, Incorporated | | Ticker Symbol: | UNH | | | WWW Address: | http://www.unitedhealthgroup.com | | CEO: | Stephen J. Hemsley | | No. of Employees: | 75,000 | | Common Issue Type: | CS | | Business Description: | A health and well-being company, which designs products, provides services and applies technologies that improve access to health and well-being services, simplify the health care experience and make health care more affordable.
|
| | | Industry Information: | HEALTH SERVICES - Health Care Plans [more like this] | | | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 29.54 | -0.02 | 29.15 | 29.55 | 29.58 | 29.69 | 28.85 | 8060821 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 34,325.5 | 1,162.0 | 1.07 | 2.40 | 0.03 | 9.8 | 0.1 | 30.25 - 16.18 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 29.56 | $ | | PE Ratio - LTM | 9.8 | |
| Market Capitalisation | 34,349.2 | mil |
| Latest Shares Outstanding | 1,162.0 | mil |
| Earnings pS (EPS) | 2.40 | $ |
| Dividend pS (DPS) | 0.03 | ¢ |
| Dividend Yield | 0.1 | % |
| Dividend Payout Ratio | 1 | % |
| Revenue per Employee | 1,082,480 | $ |
| Effective Tax Rate | 35.6 | % |
| Float | 1,156.2 | mil |
| Float as % of Shares Outstanding | 99.5 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 7.1 | % |
| Pre-Tax Profit Margin | 6.4 | % |
| Assets Turnover | 1.5 | % |
| Return on Assets (ROA) | 6.3 | % |
| Return on Equity (ROE) | 15.7 | % |
| Return on Capital Invested (ROCI) | 10.0 | % |
| Current Ratio | 0.0 | |
| Leverage Ratio (Assets/Equity) | 2.5 | |
| Interest Cover | 10.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.59 | |
| LT Debt/Total Capital | 36.0 | % |
| Working Capital pS | 0.00 | $ |
| Cash pS | 0.00 | $ |
| Book-Value pS | 19.71 | $ |
| Tangible Book-Value pS | 0.18 | $ |
| Cash Flow pS | 3.10 | $ |
| Free Cash Flow pS | 4.27 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.50 | |
| Price/Tangible Book Ratio | 166.74 | |
| Price/Cash Flow | 9.5 | |
| Price/Free Cash Flow | 6.9 | |
| P/E as % of Industry Group | 33.0 | % |
| P/E as % of Sector Segment | 93.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.03 |
| Current Dividend Yield | 0.1 |
| 5-Y Average Dividend Yield | 0.1 |
| Payout Ratio | 1.0 |
| 5-Y Average Payout Ratio | 1.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
| 
|  | | Share price performance intraday |
| 
| | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 3.5 | 102 | 77,799 | 167,342 |
| 4 Weeks | 29.69 | 25.64 | 25.95 | 13.9 | 107 | 95,931 | 1,630,832 |
| 13 Weeks | 29.88 | 23.50 | 28.18 | 4.9 | 98 | 121,022 | 7,382,324 |
| 26 Weeks | 30.00 | 23.23 | 26.60 | 11.1 | 92 | 114,302 | 14,287,795 |
| 52 Weeks | 30.25 | 16.18 | 21.01 | 40.7 | 114 | 117,565 | 29,273,637 |
| YTD | 30.25 | 16.18 | - | 11.1 | 91 | 121,011 | 27,469,546 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 28.94 | 29.00 | 26.58 | 26.76 | 25.58 | 1.07 | 1.08 |
| | | | GROWTH RATES | 5-Year Growh | R² of 5-Year Growth | 3-Year Growth |
| Revenue | 19.22 | 87.9 | 6.65 |
| Income | 7.30 | 40.9 | -2.26 |
| Dividend | 17.41 | 71.0 | 0.00 |
| Capital Spending | 13.17 | NA | 6.02 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 6.49 | NA | -3.29 |
| | | CHANGES | YTD vs. Last YTD | Curr Qtr vs. Qtr 1-Yr ago | Annual vs. Last Annual |
| Revenue % | 7.6 | 7.6 | 7.6 |
| Earnings % | 27.9 | 12.5 | -36.0 |
| EPS % | 35.0 | 18.7 | -29.8 |
| EPS $ | 0.63 | 0.14 | -1.02 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| |
| |
| |
| |
| FINANCIAL STRUCTURE RATIOS |
| Financial Leverage Ratio (Assets/Equity) | 2.69 |
| Debt Ratio | 62.77 |
| Total Debt/Equity (Gearing Ratio) | 0.62 |
| LT Debt/Equity | 0.55 |
| LT Debt/Capital Invested | 35.30 |
| LT Debt/Total Liabilities | 32.36 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 0.64 |
| Current P/E Ratio - LTM | 9.80 |
| Enterprise Value (EV)/EBITDA | 0.05 |
| Enterprise Value (EV)/Free Cash Flow | 4.57 |
| Dividend Yield | 0.1 |
| Price/Tangible Book Ratio - LTM | 166.74 |
| Price/Book Ratio - LTM | 1.50 |
| Price/Cash Flow Ratio | 9.5 |
| Price/Free Cash Flow Ratio - LTM | 6.9 |
| P/E Ratio (1 month ago) - LTM | 8.5 |
| P/E Ratio (26 weeks ago) - LTM | 10.9 |
| P/E Ratio (52 weeks ago) - LTM | 7.7 |
| 5-Y High P/E Ratio | 26.1 |
| 5-Y Low P/E Ratio | 6.0 |
| 5-Y Average P/E Ratio | 18.7 |
| Current P/E Ratio as % of 5-Y Average P/E | 52 |
| P/E as % of Industry Group | 33.0 |
| P/E as % of Sector Segment | 93.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 9.8 |
| PER SHARE FIGURES |
| Tangible Book Value pS - LTM | 0.18 |
| Book Value pS - LTM | 19.71 |
| Capital Invested pS | 27.64 |
| Cash Flow pS - LTM | 3.10 |
| Free Cash Flow pS - LTM | 4.27 |
| Earnings pS (EPS) | 2.40 |
| | | | OPERATING RATIOS | | PROFITABILITY |
| Return on Equity (ROE) | 14.33 |
| Return on Equity (ROE) - 5YEAR AVRG. | 19.6 |
| Return on Capital Invested (ROCI) | 9.27 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 14.3 |
| Return on Assets (ROA) | 5.33 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.9 |
| EBIT Margin - LTM | 7.1 |
| EBITDA Margin - LTM | 7.1 |
| |
| |
| |
| |
| |
| |
| EFFICIENCY RATIOS |
| Revenue per Employee - LTM | 1,144,107 |
| Net Income per Employee - LTM | 48,053 |
| Assets/Revenue - LTM | 66.67 |
| |
|
|  





| | |  |  | |
| |